Decreased calcineurin immunoreactivity in the postmortem brain of a patient with schizophrenia who had been prescribed the calcineurin inhibitor, tacrolimus, for leukemia

BACKGROUND: The calcineurin (CaN) inhibitor, tacrolimus, is widely used in patients undergoing allogeneic organ transplantation and in those with certain allergic diseases. Recently, several reports have suggested that CaN is also associated with schizophrenia. However, little data are currently ava...

Descripción completa

Detalles Bibliográficos
Autores principales: Wada, Akira, Kunii, Yasuto, Matsumoto, Jyunya, Hino, Mizuki, Nagaoka, Atsuko, Niwa, Shin-ichi, Yabe, Hirooki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940021/
https://www.ncbi.nlm.nih.gov/pubmed/27462157
http://dx.doi.org/10.2147/NDT.S106371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940021/
https://www.ncbi.nlm.nih.gov/pubmed/27462157
http://dx.doi.org/10.2147/NDT.S106371

Ejemplares similares